Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharmex Of Japan To Set Up Drug Factory In Brunei

This article was originally published in PharmAsia News

Executive Summary

Tokyo-based generic drug exporter and distributor Pharmex Japan will build a drug manufacturing and packaging plant in Brunei. Pharmex also aims to sell its products to other Muslim countries after receiving Halal Products Certifications and achieve annual sales of ¥200 billion. The plant is to be completed in 2010 with an investment of ¥10 billion. The generic drug market in Islam Halal-certified countries is estimated to be around ¥1,800 billion. However, to receive certification, most drug capsules that use pig gelatin have to be reformulated, and doing so requires drug makers to apply for new approvals with regulatory authorities like Japan's Ministry of Health, Labor and Welfare. Pharmex plans to use the new plant to manufacture capsule drugs and drops and liquid drugs with syringes, and to ship drugs there for packaging. (Click here for more - Japanese language
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC068139

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel